Deletion, mutation, and loss of expression of KLF6 in human prostate cancer
about
Identification and characterization of putative tumor suppressor NGB, a GTP-binding protein that interacts with the neurofibromatosis 2 proteinGene expression profiling predicts clinical outcome of prostate cancerMammalian Krüppel-like factors in health and diseasesMolecular pathology of prostate cancerKrüppel cripples prostate cancer: KLF6 progress and prospectsFrequent somatic mutations of the transcription factor ATBF1 in human prostate cancerUbiquitin E3 ligase WWP1 as an oncogenic factor in human prostate cancerTumor suppressor and hepatocellular carcinomaKLF6 induces apoptosis in prostate cancer cells through up-regulation of ATF3p21 in cancer: intricate networks and multiple activitiesNuclear expression of KLF6 tumor suppressor factor is highly associated with overexpression of ERBB2 oncoprotein in ductal breast carcinomasAberrant expression of krUppel-like factor 6 protein in colorectal cancers.TGF-beta regulates the expression of transcription factor KLF6 and its splice variants and promotes co-operative transactivation of common target genes through a Smad3-Sp1-KLF6 interactionNucleo-cytoplasmic localization domains regulate Krüppel-like factor 6 (KLF6) protein stability and tumor suppressor functionInvolvement of Kruppel-like factor 6 (KLF6) mutation in the development of nonpolypoid colorectal carcinoma.Functional role of the KLF6 tumour suppressor gene in gastric cancer.KLF6 loss of function in human prostate cancer progression is implicated in resistance to androgen deprivation.Epigenetics of prostate cancer: beyond DNA methylationEnergy restriction-mimetic agents induce apoptosis in prostate cancer cells in part through epigenetic activation of KLF6 tumor suppressor gene expression.Emerging roles of Kruppel-like factor 6 and Kruppel-like factor 6 splice variant 1 in ovarian cancer progression and treatment.KLF6-SV1 overexpression accelerates human and mouse prostate cancer progression and metastasis.Developmental regulation of yolk sac hematopoiesis by Kruppel-like factor 6Zinc and cancer: implications for LIV-1 in breast cancer.Prevalent mutations in prostate cancer.Establishment of transgenic mice carrying gene encoding human zinc finger protein 191.Downregulation of KLF6 is an early event in hepatocarcinogenesis, and stimulates proliferation while reducing differentiation.Molecular profiling of prostatic acinar morphogenesis identifies PDCD4 and KLF6 as tissue architecture-specific prognostic markers in prostate cancer.Ras promotes growth by alternative splicing-mediated inactivation of the KLF6 tumor suppressor in hepatocellular carcinoma.Expression and Function of Kruppel Like-Factors (KLF) in Carcinogenesis.Interaction of KLF6 and Sp1 regulates basigin-2 expression mediated proliferation, invasion and metastasis in hepatocellular carcinoma.Induction of Kruppel-like factor 5 expression by androgens results in increased CXCR4-dependent migration of prostate cancer cells in vitroEssential role of KLF5 transcription factor in cell proliferation and differentiation and its implications for human diseases.Acid ceramidase upregulation in prostate cancer: role in tumor development and implications for therapyBiology of Krüppel-like factor 6 transcriptional regulator in cell life and death.The complexity of prostate cancer: genomic alterations and heterogeneity.Regulatory variation: an emerging vantage point for cancer biology.Molecular pathways in prostate cancer.Analysis of human prostate cancers and cell lines for mutations in the TP53 and KLF6 tumour suppressor genes.Krüppel-like factors in mammalian stem cells and development.Effects of Kruppel-like factor 6 on osteosarcoma cell biological behavior.
P2860
Q24338893-AE4675CE-1BB8-482C-AEAF-ADDBE998B03DQ24594253-F0C68319-A38A-4191-A2CB-47611204EE25Q24612560-98BBF620-DBEC-4EEC-BCF7-A78C049D7D58Q24672410-86711155-77B0-4F77-9D38-0D32B9944245Q24684219-6F3E79A4-2915-4C82-A658-110ECF1A7150Q28238392-B3326139-EBBE-45F7-B6B1-924A2789C910Q28266601-BA0D6949-15A6-4D19-9E37-7EAAAD84F863Q28389231-9F47FCB3-2ADB-4822-B858-E97A529C2EB7Q28771723-2B1CBC52-BF67-456B-9658-D33E9C941DA7Q30436015-5B084CB7-C6D8-4FCE-84CA-B14975579669Q33529072-955A5A5D-4714-4F4D-B51E-450C6D6C0F74Q33867171-40802591-85C4-44AE-96EA-0E9125384EDCQ33899390-31501169-4075-4B95-94FD-67A056F4CD5DQ34115273-13A90295-8E2E-46C7-9117-26194DDA8D7BQ34224853-FF5810D4-27B8-4FD7-96B4-B7B77EF90A48Q34267693-17243127-1C7D-4326-A6DF-E926D545AEE2Q34289536-E63498AA-0B7F-4AA9-9A75-D1572551A572Q34505232-CD64C9E4-2677-470C-9F38-C2A28072A92DQ34696245-4AF37485-562F-417D-A673-5C770A971C40Q34698278-7882E011-5148-4EA6-858C-203E687F4A67Q34791651-FDDDCB2A-0171-492A-9AF2-A21516FB7F58Q35848611-47C45B01-73CD-42BF-A348-9CA7AB8E8FEBQ36126413-F56C0898-D39C-4889-8AB7-46F989C613BEQ36305560-047E515D-E6E2-4AF8-8A5D-C5ACFC30573DQ36474419-F77C8599-8DDF-407C-A61E-13F213E9E078Q36497062-139E2B19-BAB6-4BFA-99B1-56B075153DB8Q36582865-A35ABF06-011F-447B-896D-39FA281398DCQ37010442-27928BC6-6C82-40C2-A1F5-A4447E8ADBD2Q37313427-9216DDB9-6100-469C-B0A5-ACC67A234EC0Q37317457-B4AF35CF-F83F-40D5-928F-D945ECA02DD6Q37332423-E14B8E68-F5C4-4CAD-8120-24F98300FF41Q37486142-98A9EE1D-E97C-4B31-AC91-B19C6D05065CQ37486242-D1C6B182-D34E-428D-81E0-E4D919BF7C4AQ37820607-F8D5BFA2-2B65-456F-A2C6-D5A54318D4B9Q38058243-47CFE16F-2DBE-457A-837E-90FC5B35B077Q38164307-86102638-2ED3-4713-823B-A9CA353D1881Q38166735-AED0AE33-36C1-4F98-8A57-072A21CE4709Q38305181-FE79B372-C62B-4F8D-9504-3BB8F412F245Q38752257-B2CA7A62-1F17-42E2-A850-DE1D87EE5A93Q39209805-E72A1ACA-1151-44D1-AEB4-0EB5C2792866
P2860
Deletion, mutation, and loss of expression of KLF6 in human prostate cancer
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Deletion, mutation, and loss of expression of KLF6 in human prostate cancer
@ast
Deletion, mutation, and loss of expression of KLF6 in human prostate cancer
@en
Deletion, mutation, and loss of expression of KLF6 in human prostate cancer
@nl
type
label
Deletion, mutation, and loss of expression of KLF6 in human prostate cancer
@ast
Deletion, mutation, and loss of expression of KLF6 in human prostate cancer
@en
Deletion, mutation, and loss of expression of KLF6 in human prostate cancer
@nl
prefLabel
Deletion, mutation, and loss of expression of KLF6 in human prostate cancer
@ast
Deletion, mutation, and loss of expression of KLF6 in human prostate cancer
@en
Deletion, mutation, and loss of expression of KLF6 in human prostate cancer
@nl
P2093
P2860
P50
P3181
P1476
Deletion, mutation, and loss of expression of KLF6 in human prostate cancer
@en
P2093
Eija-Riitta Hyytinen
Heikki J Helin
Henry F Frierson
Pasi A Koivisto
Robert L Vessella
P2860
P304
P3181
P356
10.1016/S0002-9440(10)63930-2
P407
P577
2003-04-01T00:00:00Z